TY - M-10173
AU - Lodha, Apurva
TI - Recurrent Idiopathic Urticaria: Understanding Pathophysiology, Impact on Quality of Life, Comorbidities, and Advances in Treatment
T2 - Scientific Research Journal of Medical and Health Science

PY - 2024
VL - 2
IS - 2
SN - 2584-1521

AB - Recurrent idiopathic urticaria (RIU), a chronic condition affecting approximately 1% of the global population, remains a significant burden, impairing patients' quality of life and leading to multiple comorbidities. Characterized by spontaneous and unpredictable hives and angioedema, RIU can persist for weeks or months, often without an identifiable cause. This paper reviews the pathophysiology of RIU, its effect on patients' physical and mental health, common comorbidities, and current treatment strategies. We also explore recent advances in treatment options and the future of personalized medicine for managing RIU, underlining the urgent need for targeted therapies and improved patient care.

KW - Recurrent idiopathic urticaria
KW -  Chronic urticaria
KW -  Quality of life (QoL)
KW -  Autoimmune disorders
KW -  Mast cell activation
KW -  Angioedema
KW -  Omalizumab
KW -  Antihistamines
KW -  Immune system dysregulation
DO -